630 F.Supp.3d 118
D.D.C.2022Background
- DOJ (joined by NY and MN) sued to block UnitedHealth Group’s $13B acquisition of Change Healthcare, alleging horizontal and vertical antitrust harms; bench trial lasted ~2 weeks with >24 witnesses and 1,000+ exhibits.
- Change operates ClaimsXten (market-leading first-pass claims editor; ~70% share) and the largest EDI clearinghouse; OptumInsight (an Optum subsidiary of UHG) is the other major first-pass editor (~25%).
- UHG agreed to divest ClaimsXten to private-equity buyer TPG (definitive purchase agreement executed) and promulgated a firewall policy to limit sharing of competitively sensitive information (CSI).
- Government advanced three theories of harm: (1) horizontal elimination of head-to-head competition in first-pass claims editing; (2) vertical data‑misuse (Optum/Change access to rivals’ claims data would enable UHC to free‑ride and chill rivals’ innovation); and (3) vertical foreclosure (withholding/delaying EDI innovations/integrated platforms to raise rivals’ costs).
- The Court accepted the Government’s market definitions but found DOJ failed to prove by a preponderance that the merger (with the proposed divestiture) is likely to substantially lessen competition; judgment entered for defendants and the Court ordered the ClaimsXten divestiture to TPG as proposed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Horizontal: merger of two largest first-pass claims editors (ClaimsXten + OptumInsight) would create >90% share and sharply increase concentration | Combining near-70% and ~25% shares eliminates head-to-head competition and presumptively harms competition | UHG pointed to the executed divestiture of ClaimsXten to TPG, arguing divestiture will restore competition | Court found prima facie concentration but held divestiture to TPG is likely and sufficient to restore competition; plaintiff failed to prove substantial lessening of competition |
| Burden allocation re: divestiture | DOJ argued divestiture should be ignored at prima facie stage and defendant must prove it restores pre‑merger competition | UHG argued government must prove the combined (merger + divestiture) likely harms competition; defendant may rebut prima facie showing | Court agreed with UHG’s view as correct but noted outcome same under either standard; applied Government’s framework for analysis and found UHG met rebuttal burden via credible divestiture evidence |
| Vertical (data‑misuse): Optum/Change access to rivals’ claims data and secondary‑use rights will allow UHC to appropriate rivals’ innovations and chill rival innovation | Post-merger Optum will gain incremental data/use rights and will have incentive to share CSI with UHC; rivals will innovate less, substantially lessening competition | UHG emphasized longstanding firewalls, contractual protections, multi‑payer incentives, reputational and revenue costs of misuse, and lack of real‑world evidence rivals would stop innovating | Court found DOJ’s theory speculative: some incremental data rights exist but record shows strong incentives, policies, and contracts discouraging misuse; no credible evidence rivals will materially reduce innovation—prima facie failed |
| Vertical (foreclosure): UHG could withhold/delay scaled integrated EDI innovations (e.g., Transparent Network/Real‑Time Settlement) to disadvantage rivals | Post-merger UHG could deny or downgrade integrated platforms to rivals, raising rivals’ costs and foreclosing competition downstream | UHG showed concepts cited are not existing products, Optum historically sells innovations to external payers, and multi‑payer incentives and lost revenue would deter withholding | Court found theory unsupported: innovations largely conceptual, no history of withholding, and strong economic/cultural incentives to serve external payers—prima facie failed |
Key Cases Cited
- Brown Shoe Co. v. United States, 370 U.S. 294 (Sup. Ct. 1962) (Section 7 probes probabilities; Congress meant to prevent substantial lessenings of competition in their incipiency)
- United States v. Baker Hughes Inc., 908 F.2d 981 (D.C. Cir. 1990) (burden‑shifting framework for merger challenges)
- United States v. AT&T, Inc., 916 F.3d 1029 (D.C. Cir. 2019) (vertical merger analysis requires fact‑specific showing; use Baker Hughes framework)
- FTC v. H.J. Heinz Co., 246 F.3d 708 (D.C. Cir. 2001) (horizontal merger presumptions and elimination of head‑to‑head competition)
- United States v. Aetna, Inc., 240 F. Supp. 3d 1 (D.D.C. 2017) (analysis of divestiture adequacy and restoration of competitive intensity)
- United States v. Sysco Corp., 113 F. Supp. 3d 1 (D.D.C. 2015) (market definition and divestiture analysis in merger review)
- Copperweld Corp. v. Independence Tube Corp., 467 U.S. 752 (Sup. Ct. 1984) (corporate‑wide profit maximization principle relevant to vertical theories)